chrisvoncsefalvay/vaers-outcomes huggingface dataset:
ACCORDING TO FAMILY, PT NOT FEELING WELL, NAUSEA, VOMITING AND COUGHING.
Information has been received from a physician concerning a 34 year old female who on 01-OCT-2007 was vaccinated with a dose of GARDASIL. There was no concomitant medication. On 02-OCT-2007, in the morning, the patient developed a "rash all over that was itching." As of 03-DEC-2007, the patient still had a residual rash but "not as bad as before." Unspecified medical attention was sought. At the time of report, the patient had not recovered. Additional information has been requested.
Swelling of arm and injection site. With itchy ness , chills , major fatigue. After 1 week after injection
7 hours after the shot, had fatigue, feeling dizzy, unfocused, unbalanced, tired heavy over the next 2 weeks, symptoms improved about 70%. Had second shot 3 weeks later, same reaction 7 hours later. Over the next month, symptoms improved about 70% but then relapsed again. Normal neurological exam. Symptoms are fatigue, feeling heavy, lack of concentration, dizzy, unbalanced
Presents for acute visit. On Monday, she got the first SHINGRIX vaccine in her left arm, at pharmacy. Later that night it was swollen and tender. The next 2 days it gradually got worse. The swelling and redness at the injection. She had chills for two nights but did not check her temp. Yesterday she developed a rash on her abdomen, today it is better after she took BENADRYL. She never had trouble breathing.
Severe itching all over body, extreme sweating and general feeling of illness.  Did not feel better until 9/30/2013 but still continue to sweat profusely.
Severe  headache.   Severe fatigue, achy,   Nausea diarrhea  Stayed in bed for 3 days. Drank a lot of water. Missed 2 days of work.  3rd day was able to be up all day.  Did not consult physician.  Took aspirin
HEMATOMAS IN INFERIOR PART OF LEGS; PAIN ON INJECTION SITE; CHILLS; NAUSEA; HEADACHE; BODY ACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced body aches. On 06-APR-2021, the subject experienced pain on injection site. On 06-APR-2021, the subject experienced chills. On 06-APR-2021, the subject experienced nausea. On 06-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced hematomas in inferior part of legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, nausea, and headache on 08-APR-2021, was recovering from body aches, and pain on injection site, and had not recovered from hematomas in inferior part of legs. This report was non-serious.
Yes, Covid rash on lower legs, and arms of a severity 7-8 from January 2021. I was covid 19 positive from mid January 2021 through early February 2021. The rash continued from Feb 2021 through March 2021 a severity of 6-7.  The first Madera shot I received was at clinic on March 11, 2021. Two weeks later my Covid rash spread to low ankles feet  and toes. The severity was 8-9 and toes were getting progressively worse until  they started bleeding and soaking my socks that about 3" to 5" was puss and blood stained.   On 4/07/2021, I sought emergency help at clinic in which they gave me Prednisone. The rash subsided within three days taking the Prednisone  but my toes especially large toes were bleeding and looked like an open wound on large toes. On 4/8/2021 I had the second Madera vaccine.  On May 24, 2021 I returned to the clinic for emergency care concerning my toes bleeding and getting  worse. The large toe nails looked like they were going to fall off and continued to bleed and soak sock with blood and which looked like puss. The skin on both large toes kept pealing and falling off and was similar to a look of an open wound. I received a prescription of an ointment and used the ointment as directed through July 1, 2021. The bleeding and puss on large toes improved but small amounts of bleeding on left toe. Skin still peeling off.  From Mid July 2021 until now, my toes and the bottom of my feet  have progressively become number  until now at 60% to 80% numb and I am now seeking medical  help.  The left big toe still peels skin off and has minor bleeding.
Chronic Spontaneous Urticaria. I am getting really itchy patches of skin all over my body. Primarily behind my ears and around my eyes, around My groin, and my forearms. Zyrtec helps with the itchiness, but doesn't totally make it go away. regular lotion also seems to help.
Flu like symptoms, sluggish. Loss of appetite, mild chest pain, mild shortness of breath. chills, fever
Lost his hearing in his right ear; Sore right arm; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS UNILATERAL (Lost his hearing in his right ear) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A, 026B21A and 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Dec-2021, the patient experienced DEAFNESS UNILATERAL (Lost his hearing in his right ear) (seriousness criterion medically significant), PAIN IN EXTREMITY (Sore right arm) and HEADACHE (Headache). At the time of the report, DEAFNESS UNILATERAL (Lost his hearing in his right ear), PAIN IN EXTREMITY (Sore right arm) and HEADACHE (Headache) outcome was unknown.            Concomitant medication included an unspecified urinary medication to help the patient urinate. Treatment information was not provided.  The patient reported the events to his healthcare provider and was told to wait for 48 hours to see if his hearing loss resolves and if not call healthcare provider back. Patient stated he hasn't taken anything yet to treat the sore arm or headache but mentioned he planned to take something to treat. Patient had no hearing problems in the past and no known drug or food allergies.  Company Comment: This spontaneous case concerns a 67-year-old, male patient with no medical history reported and no previous hearing problems, who experienced the unexpected, serious event of deafness unilateral and other associated unexpected and expected, non-serious events. The events occurred 1 day after administration of the booster dose of the Moderna mRNA-1273 vaccine. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The rechallenge was not applicable as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 67-year-old, male patient with no medical history reported and no previous hearing problems, who experienced the unexpected, serious event of deafness unilateral and other associated unexpected and expected, non-serious events. The events occurred 1 day after administration of the booster dose of the Moderna mRNA-1273 vaccine. Treatment information was not provided. The outcomes of the events were unknown at the time of the report. The rechallenge was not applicable as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.
Patient, myself, who is also a pharmacist received second dose of Moderna COVID vaccine on 23-Apr-2021 and within 1/2 hour experienced a slight internal bodily tingling sensation including on the lips that subsided within the next 2-3 hours.  Took a nap and woke up with a slight headache and felt a little achy.  Woke up the next morning with a slight headache (felt like a sinus headache), felt achy and tired. Took ibuprofen around 1pm and 3:30pm headache went away.  Continued to feel achy and tired that night but woke up the next day (4/25) feeling fine.
Client had sat in imms room for approximately ten minutes after receiving the vaccinations prior to going to waiting room. Client was waiting for mother to take care of business with clerk for a few more minutes and she went unconscious. Her head hit the floor very hard on the back of her head. Per mother her eyes rolled back and client was non responsive. A rather large hematoma occurred approximately 5 cm by 2 cm and raised approximately .5 cm. Our physician on site assessed client and gave instructions to mother and told mother that Client has a level 1 or 2 concussion.  Ice was applied to hematoma and mother was told if confusion or lethargy was to occur she should take client to the hospital. Later that afternoon mother felt client was having trouble staying awake and kept dozing off. Client was taken to ER  (09/08/2008) and sent to another facility for observation over night. Hospital discharged client 09/09/2008 with a diagnosis of a small intracranial bleed per clients mother.  7/11/08 Reviewed ER medical records of 7/8/2007. FINAL DX: intracranial hemorrhage of subdural hematoma & subarachnoid hemorrhage Records reveal patient experienced syncope at MD office w/lightheadedness, fall, LOC x 30-45 secs w/head & neck pain when awakened.  Exam revealed tenderness at base of skull.  Transferred to higher level of care.  8/5/08 Reviewed hospital medical records of 7/8-7/9/2008. FINAL DX: SAH & small SDH s/p fall Records reveal patient continued to experience HA s/p fall. Kept overnight for observation.  Did well w/minimal scalp tenderness next AM & D/C to home w/PCP f/u.
Patient had PNEUMOVAX at 1030. Developed fever 102.5 at 1900. Arm swollen & hard area approximately 3 in x 3 in. Heat packs & BENADRYL given. No further fever & arm clear per my assessment today.
Felt woozy at a party, went to bathroom, loose bowel movement, shortly after, returned for another BM, then fainted. Lay on bathroom floor for unknown period of time. While driving  home (45 minutes), had simultaneous vomiting and diarrhea twice. Got into bed, feet were cold for hours, nausea continued less severe, one more loose BM. Feeling better in the morning, a little weak. No more nausea.
second dose past 36 days; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (second dose past 36 days) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (second dose past 36 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (second dose past 36 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No treatment information were given by the reporter. No concomitant medication was provided.
This was the Pfizer COVID-19 vaccine.   Two weeks after the second shot, I starting having severe leg pain.  Originally thought the vaccine aggrivated an existing blood clot but an ultrasound ruled that out.   Saw an orthopoedic doctor and spine specialist and was diagnosed with lower back spinal stenosis and a herniated disc.   Since then, I have been treating with non-surgical methods such as chiropractic, massaage, extensive stretching , physical therapy, personal training, two steroid epidural shots in lower back, exercise, hot epsom salt baths, and trying to maintain proper posture while sitting and walking.  More recently, the pain doctor prescribed a back brace which I have used when going on long walks or working around the house.  This has all helped but I am not back to where I was before the second COVID vaccine.   I may contemplating non-invasive back surgery as well.
Shingles; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153) via an unspecified route of administration in the right arm on 21Apr2021 at 10:00 as a single dose for COVID-19 immunisation. The patient had no medical history. The patient did not receive any medication within two weeks of vaccination. The patient previously took amoxicillin and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 12:00 the patient experienced Shingles. The event resulted in doctor or other healthcare professional office/clinic visits. Therapeutic measures were taken as a result of shingles included treatment with famciclovir 500mgtap, gabapentin 300mgcap. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Pt awoke on 7/18/07 with symptoms of generalized body aches, low grade fever, and skin tenderness lasting throughout the day. Patient took Advil 400mg in the A.M. and Advil 400mg in the afternoon with some relief from symptoms. 7/19/07 symptoms were resolved.
symptom of little soreness at injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (symptom of little soreness at injection arm) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A21A and 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Mar-2021, the patient experienced VACCINATION SITE PAIN (symptom of little soreness at injection arm). On 15-Mar-2021, VACCINATION SITE PAIN (symptom of little soreness at injection arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant product use was not provided by the reporter. Treatment included Tylenol   This case was linked to US-MODERNATX, INC.-MOD-2021-077295 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077295:second dose case
Patient was vaccinated at 9:53 AM, vaccinator checked on her 15 minutes and 30 minutes after vaccination and she had no reaction. Patient then claimed that she could not breathe and was very sleepy at 10:39 AM, she then vomited her entire breakfast and Epi-pen was administered. EMTs arrived at 10:50 AM and the EMTs took over the event upon arrival.
Nausea, 1 am through the night. Still nauseated today 3/1/21
Patient call on 11/11/2011 to report a reaction to the Pneumonia shot that was given on 11/10/2011.  Patient stated that within one hour of injection her arm was hurting and by 4:00PM she was shaking, chills and running a temp of 102 degrees.  Patient states that she is feeling better now and that everything lasted less than 24 hours.
This spontaneous case was reported by an other health care professional and describes the occurrence of VERTIGO (Head is still spinning), MALAISE (Not feeling well not at all), PAIN (Ache all over), ILLNESS (Sick) and FEELING ABNORMAL (Feel like crap, Feeling terrible) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (Head is still spinning), MALAISE (Not feeling well not at all), PAIN (Ache all over), ILLNESS (Sick), FEELING ABNORMAL (Feel like crap, Feeling terrible), PYREXIA (Fever) and CHILLS (Chills,Shivering from the fever). At the time of the report, VERTIGO (Head is still spinning) had not resolved and MALAISE (Not feeling well not at all), PAIN (Ache all over), ILLNESS (Sick), FEELING ABNORMAL (Feel like crap,Feel like shit,Feeling terrible), PYREXIA (Fever) and CHILLS (Chills,Shivering from the fever) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. No treatment details were reported. It was reported that after second dose patient was not feeling well.It was reported that the patient arm was sore for a month from other shots. This case was linked to MOD-2021-422962 (Patient Link). Reporter did not allow further contact.
Wife received a COVID vaccine less than a year later she had a miscarriage (Blighted Oveum). No parents or grandparents on either side have had a history of miscarriages. Wife is healthy person.
Missed the recommended interval inter doses; This spontaneous case was reported by a non-health professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval inter doses) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified. Concomitant products included DIGOXIN for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval inter doses). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval inter doses) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   concomitant medications included heart pills. No treatment medication for the event were reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received from a medical assistant referring to multiple patients of unknown age and gender. Information about concurrent condition, concomitant medication and medical history was not provided. On unknown dates, the patients were vaccinated with improperly stored VAQTA (dose and route unknown) (lot# M022924 with expiration date 24-JAN-2018, lot# M027879 with expiration date 24-JAN-2018) for prophylaxis. The vaccine was exposed to temperature excursion of 35Fahrenheit degree (F) for 6 hours. There was no previous temperature excursion. No data logger was involved. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA005918: US-009507513-1701USA001894: US-009507513-1701USA001895:
Nausea; Pain in arm; Tingling  in arm & left side; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old patient of unknown gender received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 28Mar2021(at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included HIV and sulfonamide allergy. Concomitant medications included mirtazapine (MANUFACTURER UNKNOWN), raltegravir (ISENTRESS), emtricitabine, tenofovir alafenamide fumarate (DESCOVY), metoprolol (MANUFACTURER UNKNOWN) and hydrocortisone (HYDROXY); all from an unknown date for an unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198), via an unspecified route of administration in the left arm on 28Feb2021 at 13:15, as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced pain/tingling in arm & left side. On an unknown date in Apr2021, 1 week after injection, the patient experienced nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain/tingling in arm & left side and nausea were not resolved at the time of reporting.   No follow-up attempts are needed. No further information is expected.
This spontaneous report was received from a physician via company representative, concerning a currently 67 year old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with a dose of PNEUMOVAX 23 for prophylaxis (dose #, route, lot # and expiration date were unknown). Concomitant medications were not reported. On an unknown date, the patient experienced injection site erythema, injection site swelling, injection site warmth, and nausea. The physician did not provide treatment as "it was a normal injection site reaction". At the time of reporting, the outcome of injection site erythema, injection site swelling, injection site warmth, and nausea was unknown. The causality assessment between the adverse events and PNEUMOVAX 23 was not provided.
Nausea; fever; Body aches; headache; sweating.; chills; This is a spontaneous report from a non-contactable consumer (patient). A patient with unspecified age and gender received second dose of bnt162b2 (Pfizer BioNtech covid-19 vaccine, Solution for injection, Lot number: EL3302), via an unspecified route on 17Feb2021 at 14:15, as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 (Pfizer BioNtech covid-19 vaccine, Solution for injection) as a single dose for covid-19 immunization. Prior to vaccination, patient was not diagnosed with COVID-19. On 18Feb2021, patient experienced nausea, fever, sweating, body aches, chills and headache. Patient did not receive any treatment for the events. The clinical outcome of the events was unknown.  No follow up attempts are possible. No further information is expected.
This spontaneous report was received from a physician via office manager refers to a patient of unknown age. On 08-JUN-2013, the patient was vaccinated with a dose of RECOMBIVAX HB, (lot # 0384AE, expiry date 02-NOV-2014), with the same lot of improperly stored RECOMBIVAX HB. Concomitant medications were not reported. No adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.
Chills and shaking until 4:00 AM.  Along with chills, symptoms of head cold.  Slight runny nose, slight pain in both ears and throat. Feverish feeling, ears, face, and feet hot. By 4:00AM  chills subsided and headache began. Also, urinated a lot during the night, but was not drinking. Very uncomfortable and couldn?t sleep. Symptoms as of 5:00 PM:  slight headache, post nasal drip, stuffy feeling head. Much better than last night.